Vimarsana
Biggest News Aggregation in the World

Page 7 - Use Authorisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Authorisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Authorisation Today - Breaking & Trending Today

Press Release: EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 - Vimarsana News

Press Release: EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19

(2) Press Release: EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 -- CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 -- CHMP scientific opinion supports national decision making within EU states on the use of the antibodies before a formal authorisation is granted during a public health emergency -- Roche and Regeneron are collaborating on developing and manufactur...

AnteoTech's AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Labmate Online - Vimarsana News

AnteoTech's AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Labmate Online

Derek Thomson, Chief Executive Officer at AnteoTech. AnteoTech’s AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Feb 23 2021 Read 941 Times AnteoTech's long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test. The test uses AnteoTech’s unique AnteoBind™ technology to support significantly improved sensitivity, and is the first rapid self-test for SARS-CoV-2 detection authorised by the United States Food and Drug Administration (FDA...

35-yr-old man rapes 13-year-old Dalit girl, tries to bury her alive - Vimarsana News

35-yr-old man rapes 13-year-old Dalit girl, tries to bury her alive

Betul, Jan 19: A 13-year-old Dalit girl has been allegedly raped by a man who then tried to bury her alive in a pit in Madhya Pradesh's Betul district, police said on Tuesday.

Nepal approves emergency use of Covishield - Vimarsana News

Nepal approves emergency use of Covishield

Nepal Government on Friday approved the emergency use of Covishield vaccine, which is being manufactured by the Serum Institute of India (SII).

A vaccination tax is needed for equity and public confidence - On Line Opinion - Vimarsana News

A vaccination tax is needed for equity and public confidence - On Line Opinion

Vaccination is not without risk. The Prime Minister, Scott Morrison, has declared indemnification for vaccine manufacturers for adverse vaccine outcomes. What is missing is compensation for vax-injured individuals. The USA has had a vaccine injury compensation scheme (VICS) for the past three decades. The US National Vaccine Injury Compensation Program (VICP) has paid out US$4.4 billion (A$5.7 billion) for 7,575 vax injuries (from 1989 through 2020). The average settled claim was US$585,000 (A$760,000). There were 1.4 compensated injuries per million distributed vaccine doses. Of the total va...